Emcure Pharmaceuticals Share Price
1924.80+70.10 (+3.78%)
+40.35% past 1 Year
Emcure Pharmaceuticals is one of the leading Indian pharmaceutical companies engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas. The company’s
Corporate filings & documents
Announcements
Dispatch of letter to the members whose e-mail addresses are not registered with the Company/Depository Participants
2 days agoDispatch of letter to the members whose e-mail addresses are not registered with the Company/Depository Participants
2 days agoIntimation of schedule of Investor Meet on Friday September 04 2026
2 days agoIntimation of schedule of Investor Meet on Friday September 04 2026
2 days agoReaffirmation of Credit Ratings by CARE Ratings Limited
2 days agoReaffirmation of Credit Ratings by CARE Ratings Limited
2 days agoNewspaper Advertisement of Notice of the 45th Annual General Meeting and e-voting information
5 days agoNewspaper Advertisement of Notice of the 45th Annual General Meeting and e-voting information
5 days agoBusiness Responsibility and Sustainability Report for the Financial Year 2025-26
6 days agoBusiness Responsibility and Sustainability Report for the Financial Year 2025-26
6 days agoNotice of the 45th Annual General Meeting of Emcure Pharmaceuticals Limited
6 days agoNotice of the 45th Annual General Meeting of Emcure Pharmaceuticals Limited
6 days agoAnnual Report of the Company for the Financial Year 2025-26
6 days agoAnnual Report of the Company for the Financial Year 2025-26
6 days agoAllotment of 19 100 Equity Shares pursuant to exercise of ESOPs under Emcure - Employee Stock Option Scheme 2013
1 week agoAllotment of 19 100 Equity Shares pursuant to exercise of ESOPs under Emcure - Employee Stock Option Scheme 2013
1 week agoTranscript of Earnings Call - Q1 FY27
3 weeks agoTranscript of Earnings Call - Q1 FY27
3 weeks agoUpdate on USFDA inspection at our formulations facility located at Sanand Ahmedabad Gujarat India
3 weeks agoUpdate on USFDA inspection at our formulations facility located at Sanand Ahmedabad Gujarat India
3 weeks agoAnalyst/ Investor Meet on Tuesday September 22 2026
3 weeks agoAnalyst/ Investor Meet on Tuesday September 22 2026
3 weeks agoAnalyst/ Investor Meet on Thursday September 17 2026
3 weeks agoAnalyst/ Investor Meet on Thursday September 17 2026
3 weeks agoAnalyst/ Investor Meet on Tuesday September 01 2026
3 weeks agoAnalyst/ Investor Meet on Tuesday September 01 2026
3 weeks agoAnalyst/ Investor Meet on Tuesday August 18 2026
3 weeks agoAnalyst/ Investor Meet on Tuesday August 18 2026
3 weeks agoAnalyst/Investor Meet on Wednesday August 12 2026
3 weeks agoAnalyst/Investor Meet on Wednesday August 12 2026
3 weeks agoNewspaper Publication of Unaudited Financial Results of the Company for the quarter ended June 30 2026
3 weeks agoNewspaper Publication of Unaudited Financial Results of the Company for the quarter ended June 30 2026
3 weeks agoAudio recording of Earnings Call - Q1 FY27
4 weeks agoAudio recording of Earnings Call - Q1 FY27
4 weeks agoIntimation of date of the 45th Annual General Meeting and Record Date for payment of Final Dividend on Equity Shares for the Financial Year March 31 2026
4 weeks agoIntimation of date of the 45th Annual General Meeting and Record Date for payment of Final Dividend on Equity Shares for the Financial Year March 31 2026
4 weeks agoIntimation under Regulation 30 of the SEBI (LODR) Regulations 2015 - Change in composition of the Board of the Company
4 weeks agoIntimation under Regulation 30 of the SEBI (LODR) Regulations 2015 - Change in composition of the Board of the Company
4 weeks agoPresentation on Unaudited Financial Results for the quarter ended June 30 2026
4 weeks agoPresentation on Unaudited Financial Results for the quarter ended June 30 2026
4 weeks agoUnaudited Financial Results (Standalone and consolidated) for the quarter ended June 30 2026
4 weeks agoUnaudited Financial Results (Standalone and consolidated) for the quarter ended June 30 2026
4 weeks agoOutcome of Board Meeting held on August 06 2026
4 weeks agoOutcome of Board Meeting held on August 06 2026
4 weeks agoUpdate on completion of acquisition of shares of Gennova Biopharmaceuticals Limited
1 month agoUpdate on completion of acquisition of shares of Gennova Biopharmaceuticals Limited
1 month agoIntimation under Regulation 30 of the SEBI (LODR) Regulations 2015 - Completion of 2nd term of Independent Director
1 month agoIntimation under Regulation 30 of the SEBI (LODR) Regulations 2015 - Completion of 2nd term of Independent Director
1 month agoPress Release titled "Emcure to Expand the Use of Poviztra for MASH Indication Following CDSCO Approval".
1 month agoPress Release titled "Emcure to Expand the Use of Poviztra for MASH Indication Following CDSCO Approval".
1 month agoAnnual reports
Corporate Actions
Date
Type
Details
2026-09-04
Dividend
3.6
2025-08-14
Dividend
3.0
Company details
Registered office
Plot No. P-1 & P-2 I T - B T Park, Phase- I I M I D C, Hinjawadi Pune Maharashtra PIN: 411057 Tel No: 020-35070033 / 35070000 Fax No: 020-35070060 Email: [email protected] Internet: www.emcure.com
Registrars
C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra C 101, 247 Park LBS Marg Vikhroli (West) PIN: Tel No: +91 810 811 8484 Fax No: 91-022-49186060 Email: [email protected] Internet: https://in.mpms.mufg.com/
Management
Berjis Desai, Chairman
Satish Mehta, Managing Director & Chief Executive Officer
Sunil Mehta, Whole Time Director
Mukund Gurjar, Whole Time Director
Namita Thapar, Whole Time Director
Samit Satish Mehta, Whole Time Director
Vijay Gokhale, Non Executive Independent Director
Shailesh Ayyangar, Non Executive Independent Director
Vidya Yeravdekar, Non Executive Independent Director
CS Muralidharan, Non Executive Independent Director
Amruta Yangalwar, Company Secretary & Compliance Officer
Details
BSE 544210
NSE EMCURE
ISIN INE168P01015